Active Clinical Trials

Aortic Valve Studies

NCT Number / ClinicalTrials.gov ID NumberStudy NameSponsorStudy PopulationPrincipal InvestigatorStudy ContactStudy Length
NCT03735667 (external link)ACURATE IDEBoston ScientificAll risk, symptomatic, severe ASAbhijeet Dhoble, MDAnna Menezes10 years
NCT04415047 (external link)ALIGN-ARJenaValve Technology, Inc.High risk, symptomatic, severe ARSukhdeep Basra, MDChandni Patel5 years
NCT05172960 (external link)ALLIANCEEdwards LifesciencesSymptomatic, severe ASAbhijeet Dhoble, MDAnna Menezes10 years
NCT05172973 (external link)ALLIANCE AVIVEdwards LifesciencesHigh Risk, symptomatic, severe ASSukhdeep Basra, MDChandni Patel
NCT05932615 (external link)ENVISIONAbbott Medical DevicesIntermediate or low risk for open surgical aortic valve replacementAbhijeet Dhoble, MDAnna Menezes3 years
NCT05295628 (external link)EMBLOKInnovative Cardiovascular SolutionsAbhijeet Dhoble, MDAnna Menezes2 years
NCT02677974 (external link)ONXCryoLifePatients with recent On-X Aortic Prosthetic Heart ValveRobert Hetz, MDMadiha Hassan12 years
NCT04889872 (external link)PROGRESSEdwards LifesciencesSymptomatic, moderate ASBiswajit Kar, MDChandni Patel10 years
NCT04618718 (external link)PROTEMBO CProtembis GmbHAbhijeet Dhoble, MDAnna Menezes2 years

 

Coronary Artery Studies

NCT Number / ClinicalTrials.gov ID NumberStudy NameSponsorStudy PopulationPrincipal InvestigatorStudy ContactStudy Length
NCT00756379 (external link)CenturyUTHealth HoustonSuspected or known coronary artery diseaseK. Lance Gould, MDClaudette Mitchell18 years
NCT05102019 (external link)COSIRA-IINeovasc Inc.Symptomatic CAD, angina CCS 3 or 4, functionally limited due to anginaSalman A. Arain, MDAnna Menezes5 years
NCT03947619 (external link)DTU-STEMIAbiomedAcute anterior STEMI with ≥2 mm in 2 or more contiguous anterior leads or ≥ 4 mm total ST segment deviation sum in the anterior leads V1-V4 and anterior wall motion abnormality noted on a diagnostic quality left ventriculogram or ECGSachin Kumar, MD and Marwan Jumean, MDChandni Patel10 years
NCT04763200 (external link)PROTECT IVAbiomedCCS or NSTEMI with an LVEF ≤40%, baseline left ventricular function: Either 2A or 2BSachin Kumar, MD and Marwan Jumean, MDChandni Patel5 years

 

Mitral Valve Studies

NCT Number / ClinicalTrials.gov ID NumberStudy NameSponsorStudy PopulationPrincipal InvestigatorStudy ContactStudy Length
NCT03242642 (external link)APOLLOMedtronicAll risk, symptomatic, moderate to severe or severe MRRichard Smalling, MD, PhDAnna Menezes5 years
NCT03706833 (external link)CLASP IID/IIFEdwards LifesciencesIID - Prohibitive risk, symptomatic, severe DMR IIF - All risk, symptomatic, severe FMRAbhijeet Dhoble, MDAnna Menezes5 years
NCT04198870 (external link)REPAIR MRAbbottModerate risk, symptomatic, severe DMRRichard Smalling, MD, PhDAnna Menezes10 years
NCT03433274 (external link)SUMMITAbbottAll risk, symptomatic, moderate to severe or severe MRSukhdeep Basra, MDChandni Patel5 years
NCT04153292 (external link)ENCIRCLEEdwards LifesciencesMR ≥ 3+, NYHA functional class ≥ IIBiswajit Kar, MDChandni Patel10 years

 

Tricuspid Valve Studies

NCT Number / ClinicalTrials.gov ID NumberStudy NameSponsorStudy PopulationPrincipal InvestigatorStudy ContactStudy Length
NCT04482062 (external link)TRISCEND IIEdwards LifesciencesAll risk, symptomatic, severe TRAbhijeet Dhoble, MDAnna Menezes5 years
NCT04097145 (external link)CLASP II TREdwards LifesciencesModerate or greater risk, symptomatic, severe TRAbhijeet Dhoble, MDAnna Menezes5 years

 

Lung Studies

NCT Number / ClinicalTrials.gov ID NumberStudy NameSponsorStudy PopulationPrincipal InvestigatorStudy ContactStudy Length
NCT05050955 (external link)ALAMOCareDx≤ 90 days post-LungCare™ transplantRahat Hussain, MDChandni Patel6 years
NCT05415137 (external link)Efficacy and Safety of Intravenous Efzofitimod in Patients with Pulmonary SarcoidosisaTyr Pharma6+ month symptomatic history of pulmonary sarcoidosis and MRC dyspnea scale grade of at least 1 and KSQ-Lung score ≤70Rahat Hussain, MDChandni Patel3 years
NCT04708782 (external link)TETONUnited Therapeutics≥40 years of age, diagnosis of IPF, FVC ≥45% predicted at screeningRahat Hussain, MDChandni Patel4 years

 

Stroke Prevention

NCT Number / ClinicalTrials.gov ID NumberStudy NameSponsorStudy PopulationPrincipal InvestigatorStudy ContactStudy Length
NCT04226547 (external link)CATALYSTAbbottDocumented afib at high risk for stroke (CHA2DS2-VASc score of ≥3)Abhijeet Dhoble, MDAnna Menezes5 years
NCT05119179 (external link)OCCLUFLEXOcclutechPFO positive with cryptogenic stroke at any point in the pastAbhijeet Dhoble, MDAnna Menezes5 years
NCT03309332 (external link)PFO PASAbbottPFO positive with cryptogenic stroke in the past 547 daysRichard Smalling, MD, PhDAnna Menezes5 years

 

Vascular and Endovascular Studies

NCT Number / ClinicalTrials.gov ID NumberStudy NameSponsorStudy PopulationPrincipal InvestigatorStudy ContactStudy Length
NCT02622542 (external link)ACUTE-BUTHealth HoustonDiagnosed with uncomplicated ABADHarleen K Sandhu, MD, MPHHarleen K Sandhu, MD, MPH8 years
NCT02380716 (external link)ARISEW.L. Gore & AssociatesTreatment of DeBakey Type I/II aortic dissections with the GORE® Ascending Stent GraftAnthony Estrera, MDMadiha Hassan9 years
NCT01937949 (external link)Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent GraftsGustavo Oderich, MDJuxtarenal, suprarenal or type IV thoracoabdominal aortic aneurysm with a diameter ≥ 5.0 cm or 2 times the normal aortic diameter, aneurysm with a history of growth ≥ 0.5 cm per yearGustavo Oderich, MDSafa Savadi Osgouei, MD8 years
NCT02089607 (external link)Complex Abdominal, TAAA, Aortic Arch Aneurysm or Dissections with Fenestrated/​Branched Stent GraftCook MedicalThoracoabdominal aortic aneurysm with a diameter ≥ 5.5 cm or 2 times the normal aortic diameter, aneurysm with a history of growth ≥ 0.5 cm per year.Gustavo Oderich, MDSafa Savadi Osgouei, MD6 years
NCT05442489 (external link)TAMBEW.L. Gore & AssociatesAortic aneurysm involving the visceral vessels: Fusiform aneurysm diameter ≥ 5 cm Saccular aneurysm (no diameter requirement) Rapid aneurysm growth (≥ 5 mm in one year)Naveed Saqib, MDMadiha Hassan
NCT03536312 (external link)TITAN:SvSOttawa Heart Institute Research CorporationAscending aortic aneurysmAnthony Estrera, MDChandni Patel8 years

 

Other Studies

NCT Number / ClinicalTrials.gov ID NumberStudy NameSponsorStudy PopulationPrincipal InvestigatorStudy ContactStudy Length
NCT05064709 (external link)AIM HIGHerImpulse DynamicsDiagnosed with symptomatic heart failure,
LVEF ≥40 and ≤60%
Marwan Jumean, MDChandni Patel4 years
NCT04331769 (external link)CORCINCH-HFAncora HeartEjection Fraction: ≥20% and ≤40% and LV end-diastolic diameter ≥55 mm measured TTEMarwan Jumean, MDChandni Patel10 years
NCT05069558 (external link)Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with PrediabetesUTHealth HoustonDr. Absalon GutierrezJoseph. B. McCormick, MD/a>4 years
NCT03773575 (external link)PREVENAThomas Jefferson UniversityPatients undergoing above-the-knee or below-the-knee amputationRana Afifi, MDMadiha Hassan5 years
NCT05017935 (external link)RADIANCE CAPReCor MedicalDocumented hypertension, BP ≥140/90Konstantinos Charitakis, MDAnna Menezes5 years